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A B S T R A C T
Objectives: To investigate the pattern of tuberculosis (TB) care initiation and risk factors for TB diagnostic
delay in The Gambia.
Methods: In this cross-sectional study, adult patients diagnosed with pulmonary TB (pTB) in public
facilities in the Greater Banjul Area of The Gambia were consecutively recruited from October 2016 to
March 2017. Diagnostic delay was defined as >21 days from the onset of at least one symptom suggestive
of pTB to diagnosis. Logistic regression analyses were used to investigate risk factors for diagnostic delay.
Results: Overall, 216 pTB patients were included in the study; the median (Interquartile Range (IQR)) age
was 30 (23–39) years and 167 (77%) were male patients. Of the 216 patients, 110 (50.9%) of them initiated
care-seeking in the formal and informal private sector and 181/216 (83.8%) had TB diagnostic delay. The
median (IQR) duration from the onset of symptoms to TB diagnosis was 34 (28–56) days. Age groups 18–
29 years (aOR 3.2; 95% CI 1.2–8.8 [p = 0.02]) and 30–49 years (aOR 5.1; 95% CI 1.6–16.2 [p = 0.006]) and
being employed (aOR 4.2; 95% CI 1.7–10.5 [p = 0.002]) were independent risk factors for TB diagnostic
delay.
Conclusion: There is considerable TB diagnostic delay in The Gambia, and this is likely to be worsened by
the COVID-19 pandemic.
© 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
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Globally, tuberculosis (TB) is the leading cause of death from a
single infectious disease (Boggiano et al., 2017). An estimated 10
million new cases of TB and 1.5 million TB deaths were reported in
2018 (World Health Organization (WHO), 2019). The current public
health strategy for the control of TB in high-burden settings is
geared towards the early detection of infectious TB patients,
mostly through passive, as opposed to active, case detection,
followed by the prompt initiation of treatment (Sreeramareddy
et al., 2014). In low- and middle-income countries (LMICs) with
high TB burden, the focus has been on passive case detection of TB
in national health systems (Fuge et al., 2018). Passive TB case* Corresponding author at: Clinical Research Department, Faculty of Infectious
and Tropical Diseases, LSHTM, Keppel Street, London WC1E 7HT, United Kingdom.
E-mail address: Toyin.Togun@lshtm.ac.uk (T. Togun).
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1201-9712/© 2020 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).detection is influenced by several factors, including the subject’s
perception of the severity of the illness, awareness of the likely
cause of their symptoms, stigma, access to health facilities well-
equipped to screen for TB and on the level of TB symptoms
recognition that will trigger an investigation by the care provider at
the time of first presentation by the patients (Shewade et al., 2019).
However, this approach has been less effective in LMICs where
there is poor access to health care facilities with appropriate
diagnostic tools, poor TB symptom awareness and inadequate
community and social mobilisation to support effective passive
case finding (Shewade et al., 2019). This has resulted in
considerable TB diagnostic delay that negatively impacts the
whole cascade of care, fuelling the increasing number of missed
cases of TB each year, presently estimated globally at 3 million
(World Health Organization (WHO), 2019).
There is growing interest in the quality of TB care in TB endemic
settings (Satyanarayana et al., 2015). The provision of high quality
of care for TB patients, with emphasis on rapid and accurateciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Socio-demographic and clinical characteristics of study participants (N = 216).
Variables n (%)
Age (years)
18–29 102 (47.2)
30–49 83 (38.4)
50 31 (14.4)
Sex
Male 167 (77.3)
Female 49 (22.7)
Marital status
Married 91 (421)
Unmarried 125 (57.9)
Formal education
Yes 196 (90.7)
None 20 (9.3)
Tribe
Mandinka 71 (32.9)
Wolof 36 (16.7)
Fula 45 (20.8)
Jola 31 (14.3)
Others 33 (15.3)
Employment status
Employed 110 (50.9)
Unemployed 106 (49.1)
Symptoms
Cough 214 (99.1)
Fever 196(90.7)
Weight loss 211 (97.7)
Malaise 214 (99.1)
Loss of appetite 194 (89.8)
Drenching night sweat 131(60.6)
Haemoptysis 30(14.0)
Care Provider Pattern
Public facility only 57 (26.4)
Mixed public and private 159 (73.6)
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objectives of the End TB Strategy of the WHO (Uplekar et al., 2015).
Surya et al. reported that 75% of TB patients in Indonesia initiated
TB care in the private sector lacking appropriate diagnostic
facilities for TB (Surya et al., 2017). A combined patients pathway
analysis (PPA) from 13 countries, which included six African
countries with the highest TB burden on the continent, reported
that about 60% of all TB patients initiated care from the private
sector, and less than 50% of estimated TB patients had documented
treatment success (Chin and Hanson, 2017). A cascade of TB patient
care analysis in South Africa reported that only 53% of TB patients
in South Africa were diagnosed and successfully treated (Naidoo
et al., 2017). Taken together, the current public health approach for
the control of TB in high-burden countries is characterised by TB
diagnostic delay as well as delay in the initiation of effective
treatment with poor rates of treatment success, all of which are
considered surrogates for the quality of TB care (Cazabon et al.,
2017).
The diagnosis of TB and initiation of treatment in The Gambia is
based primarily on passive case detection (Lienhardt et al., 2001).
Therefore, we aimed to investigate the pattern of TB care initiation
and the risk factors associated with TB diagnostic delay, among
newly diagnosed adult pulmonary TB (pTB) patients in The
Gambia.
Methods
Settings, sites and study participants
In The Gambia, the incidence rate of TBis 174 cases/100,000
population (World Health Organization (WHO), 2019), while the
prevalence of HIV infection among adults aged 15–49 years is 1.6%
(Gambian Ministry of Health and Social Welfare, 2016). Also, 7% of
newly diagnosed TB patients in The Gambia are HIV positive (Stop
TB Partnership, 2018).
This exploratory cross-sectional study was conducted in the
Greater Banjul Area (GBA) of The Gambia between October 2016
and March 2017, using the TB Case-Contact (TBCC) platform at the
Medical Research Council Unit The Gambia at LSHTM (MRCG at
LSHTM) (Hill and Ota, 2010). Ethical approval was obtained from
the Gambia Government/MRC joint ethics committee. The GBA is a
mixed urban, peri-urban and rural setting, with an approximate
population of 700,000 (Egere et al., 2016), where an estimated 70%
of all TB cases in The Gambia are notified (Gambian National
Leprosy and Tuberculosis Control Programme (NLTP), 2012).
Our study population were consecutive adult subjects (age 18
years) who were newly diagnosed with sputum smear positive pTB
disease at either of three health centres (Brikama, Fajikunda and
Serrekunda Health Centres) or the MRC Gambia TB clinic in the
GBA. Sputum smear microscopy is still the first and only tool for
routine diagnosis of TB in most public health facilities providing
comprehensive primary health care, including TB diagnosis, in The
Gambia. GeneXpert test is additionally available at the MRC
Gambia at entry point for potential research participants in the
TBCC cohort. The TB clinics in these four public health facilities
collectively account for approximately 80% of all TB diagnosis in
the GBA annually (Gambian National Leprosy and Tuberculosis
Control Programme (NLTP), 2012; Lienhardt et al., 2001).
Study participants were interviewed by trained nurse/field
workers within one week of their TB diagnosis. A structured
questionnaire was used to collect data on the sociodemographic
characteristics, symptoms at presentation and health care seeking
behaviours of the study participants (see supplementary material).
All study participants were initiated on standard anti-TB treatment
by direct observation according to the Gambian National TB
Guidelines (Gambian National Leprosy and Tuberculosis ControlProgramme (NLTP), 2012). Health care providers are persons
consulted by patients for their ailments with the aim of obtaining
advice or prescription, as previously described (Lienhardt et al.,
2001).
Data analysis and statistical methods
TB diagnostic delay was defined as more than 21 days from the
onset of at least one symptom of TB before diagnosis, according to
the WHO (World Health Organization (WHO), 1997). Participants’
characteristics were summarised using numbers (percentages) for
categorical variables and median (interquartile range [IQR]) for
quantitative variables. We investigated factors associated with TB
diagnostic delay by univariate and multivariable logistic regression
analysis. Age, sex and variables with p-value < 0.20 in the
univariate analysis were included in the multivariable analysis. All
analyses were performed by using the STATA version 16 (StataCorp,
College Station, Texas, United States). p-values < 0.05 were
considered statistically significant.
Results
All the 216 subjects diagnosed with sputum smear positive pTB
in the four public facilities over the study period agreed to
participate in the study. The median (IQR) age of the study
participants was 30 (23–39) years, and all of them were HIV
negative. One hundred and sixty-seven (77.3%) were male patients
and 106 (49.1%) were unemployed (Table 1). Cough (214 [99.1%])
O.A. Owolabi, A.O. Jallow, M. Jallow et al. / International Journal of Infectious Diseases 101 (2020) xxx–xxx 3and malaise (214 [99.1%]) were the most frequent symptoms at
presentation, followed by weight loss (211 [97.7%]), fever (196
[90.7%]), loss of appetite (194 [89.8%]), drenching night sweat (131
[60.6%]) and haemoptysis (30 [14.0%]).
TB care-seeking pattern
Of the 216 patients with pTB, 110 (50.9%) initiated TB care-
seeking in the formal and informal private sector, comprising
(traditional healers (n = 9), dispensaries (n = 8), pharmacy shops
(n = 49) and private clinics (n = 44). (Figure 1). The median (IQR)
number of visits to health facilities before TB diagnosis were 3 (2–
4) visits. The median (IQR) duration from the onset of at least one
symptom suggestive of TB to diagnosis was 34 (28 and 56) days,
and 181 patients (83.8%) had more than 21 days from the onset of
TB symptoms to diagnosis. One hundred and fifty-nine (73.6%) out
of all the newly diagnosed participants with pTB in this analysis
reported that they had sought care at both private and public
health care facilities before diagnosis.
Factors associated with TB diagnosis delay
In the univariate analysis, we found that pTB patients aged 30–
49 years (crude OR 5.2; 95% CI 1.8–15.2 [p = 0.003]) and those
employed (crude OR 3.6; 95% CI 1.6–8.2 [p = 0.001]) had
significantly higher odds of TB diagnostic delay relative to patients
aged 50 years and those with no employment, respectively. Sex,
marital status, tribe, having formal education and the care provider
pattern were not associated with TB diagnosis delay (Table 2).
The multivariable logistic regression model, with the inclusion
of age group categories, sex and variables in the univariate analysis
with p-value < 0.20 as covariates, showed that age groups 18–29
years (aOR 3.2: 95% CI 1.2–8.8 [p = 0.02]) and 30–49 years (aOR 5.1:
95% CI 1.6–16.2 [p = 0.006]), and being employed (aOR 4.2: 95% CI
1.7–10.5 [p = 0.002]) were strong, significant and independent risk
factors of TB diagnostic delay.
Discussion
Our study reports on the care-seeking pattern and diagnostic
delay among newly diagnosed adult patients with pTB in The
Gambia, West Africa, prior to the COVID-19 pandemic. We found
that half of all newly diagnosed adult pTB patients in the GBA
initiated care in the formal or informal private sector, and
approximately 84% had delays to their TB diagnosis as defined
by the WHO i.e. more than 21 days from the onset of symptomsFigure 1. Initiation of TB care: Distribution of the facilities at which newly
diagnosed patients with pTB first sought care in the Greater Banjul Area of The
Gambia (N = 216).suggestive of TB to diagnosis (World Health Organization (WHO),
1997). Also, the odds of TB diagnostic delay were, at least, three
times higher in patients younger than 50 years of age and those
who were employed than in older-aged patients or those who were
unemployed. In The Gambia, sputum smear microscopy is still the
first and only diagnostic test for TB in the routine public health
system. The diagnosis of TB and provision of anti-TB drugs are only
available in public health facilities (Gambian National Leprosy and
Tuberculosis Control Programme (NLTP), 2012). Although 49% of
our study participants initiated care-seeking in public facilities, the
finding that more than 80% of all participants in this study had TB
diagnostic delay and our finding of no significant difference in the
odds of TB diagnostic delay between participants who sought care
in public facilities only and those who had sought care in both
public and private facilities before TB diagnosis, highly suggest that
there could be delays in testing and missed opportunities for early
TB diagnosis even in the public health facilities where TB
diagnostic tests are available. The recognised limitations of sputum
smear microscopy as the only TB diagnostic test available in
routine public health system in The Gambia could have contributed
to this delay. Thus, the findings further highlight the need for
sputum smear microscopy replacement with WHO-endorsed rapid
diagnostic tests (World Health Organization (WHO), 2020), and the
potential for scaling up of molecular diagnostic tests for TB in The
Gambia.
Furthermore, we found that TB patients made an average of
three visits to health care providers while almost three-quarters
sought care at both private and public health care facilities before
diagnosis of TB was made. Our finding that TB patients made an
average of three visits to health care facilities before diagnosis is
similar to that of a systematic review of 23 studies from different
parts of India in which patients made an average of three visits to
health care providers before diagnosis (Sreeramareddy et al.,
2014). This finding, however, seems to be an improvement over the
finding in a previous study conducted in The Gambia that TB
patients visited an average of four health care providers, and
possibly even greater number of actual visits, before TB diagnosis
(Lienhardt et al., 2001). However, another study from Italy, a high-
income country, reported that TB patients had an average of two
visits before diagnosis (Peri et al., 2018).
Approximately 51% of the adult TB patients in our study
initiated care in the formal and informal private sector where
studies in LMICs have shown that such providers often lack the
knowledge of TB symptoms, and TB diagnostic facilities are
frequently unavailable (Cazabon et al., 2020; Daniels et al., 2019;
Das et al., 2015). This finding is comparable to the report of a
combined PPA from 13 high TB burden countries in Africa and
Southeast Asia, where about 60% of all TB patients initiated care in
the private sector (Chin and Hanson, 2017).
The median duration from the onset of TB symptoms to
diagnosis in our study was 34 days, which is comparable to the 30
days reported from a study in Ethiopia (Fuge et al., 2018). This
duration in our study is, however, shorter than durations in the
excess of 45 days reported from studies in Angola, Tunisia and
Brazil (Ben Amar et al., 2016; Machado et al., 2011; Segagni
Lusignani et al., 2013). In contrast to our study, these studies
included patients with smear-negative TB, extra-pTB and culture-
positive TB disease, which could explain the longer duration from
the onset of TB symptoms to diagnosis.
Our study showed that age <50 years and being employed were
strong and independent risk factors for TB diagnosis delay. These
probably reflect the socio-economic realities of subjects battling
ill-health in the low-income setting of The Gambia, where the need
for economic survival trumps health care seeking. Older aged
patients are probably retired and/or fully dependent on relatives
for care. However, in contrast to our report, a systematic review of
Table 2
Determinants of TB diagnostic delay.
Variables Crude OR (95% CIa) Crude p Adjusted OR (95% CIa) Adjusted p
Age (years)
18–29 2.2 (0.9–5.5) 0.09 3.2 (1.2–8.8) 0.02
30–49 5.2 (1.8–15.2) 0.003 5.1 (1.6–16.2) 0.006
50 Reference Reference
Sex
Male Reference Reference
Female 0.8 (0.4–1.9) 0.64 1.3 (0.5–3.3) 0.59
Marital status
Unmarried Reference
Married 1.3 (0.6–2.7) 0.52
Formal education
No Reference Reference
Yes 0.3 (0.1–1.9) 0.19 0.1 (0.1–1.2) 0.07
Employed
No Reference Reference
Yes 3.6 (1.6–8.2) 0.001 4.2 (1.7–10.5) 0.002
Tribe
Mandinka Reference
Wolof 2.1 (0.7–7.0) 0.21
Fula 2.1 (0.7–6.4) 0.17
Jola 1.4 (0.5–4.2) 0.56
others 1.2 (0.4–3.5) 0.72
Symptoms
Cough
No Reference
Yes 5.3 (0.3–86.7) 0.24
Weight loss
No Reference Reference
Yes 3.6 (0.6–22.4) 0.17 5.1 (0.7–39.5) 0.12
Fever
No Reference
Yes 0.9 (0.3–3.3) 0.88
Loss of appetite
No Reference
Yes 1.6 (0.6–4.7) 0.39
Haemoptysis
No Reference
Yes 1.0 (0.3–2.7) 0.94
Drenching night sweat
No Reference
Yes 1.5 (0.7–3.1) 0.27
Care provider pattern
Public facility only Reference
Mixed public and private 1.1 (0.5–2.6) 0.75
a 95% CI = (95% confidence interval).
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with delays in TB diagnosis (Cai et al., 2015). We did not find any
association between gender, marital status, having formal educa-
tion and TB diagnostic delay. Other studies had reported that
female gender was associated with TB diagnostic delay (Ben Amar
et al., 2016; Cai et al., 2015; Ndeikoundam Ngangro et al., 2012; Peri
et al., 2018; Saldana et al., 2013).
It is very likely that the care-seeking behaviour and delays in TB
diagnosis in The Gambia will be further impacted by the advent of
the COVID-19 pandemic. Our recently published review article on
the impact of the COVID-19 pandemic on TB patients and control
programmes highlighted the likely grave consequences for existing
and undiagnosed TB patients particularly in LMICs where TB isendemic and health services poorly equipped (Togun et al., 2020).
This assertion is supported by another study that modelled the
impact of the COVID-19 response on TB in high-burden countries
that suggests that the two months of lockdown and of recovery will
add an excess of 1.8 million TB cases over the next five years (Stop
TB Partnership, 2020).
Our study has limitations: the small sample size might not have
allowed sufficient statistical power to detect meaningful differ-
ences across strata. Also, the study was conducted in the largely
urban Greater Banjul Area of The Gambia, and the findings might
not be generalisable to the rural areas of The Gambia. However, the
overwhelming majority of TB cases in The Gambia are notified in
the densely populated GBA.
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This exploratory study has highlighted the considerable delay in
the diagnosis of TB in The Gambia, and provides a benchmark
against which we can measure efforts to better understand and
improve the overall quality of TB care in the country during the
COVID-19 pandemic. There is an urgent need for larger prospective
studies to better understand TB patients’ pathways to care,
particularly the roles of age and socio-economic factors in care-
seeking behaviour of presumed TB patients, and the best
modalities for engaging the private sector in the national TB
control programme. A standard cascade of TB care analysis is also
needed to accurately estimate the proportions of total TB patients
evaluated, diagnosed, initiated on treatment and successfully
treated, and the losses at each step of the cascade.
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